Mild symptomatic SARS-CoV-2 infection and cognitive decline


  • There is evidence of cognitive decline among adults aged over 40 years following mild symptomatic coronavirus-19 (COVID-19) infection.

Why this matters

  • Studies report COVID-19 related neurological complications closely following severe illness; however, there is little to no published information on delayed complications of moderate-to-mild infection in any population.

  • The occurrence of cognitive decline in mild COVID-19 adds to growing knowledge of both short- and long-term effects of this virus; and highlights the importance of thorough investigation of patients with a COVID-19 history for further clarification of its sequelae.